Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Mt. Sinai Hospital, New York

Corning Center for Clinical Research, Corning

DermDox Centers for Dermatology, Hazleton

Virginia Clinical Research, Inc., Norfolk

Wake Research Associates, LLC, Raleigh

Synexus, Greer

Leavitt Medical Associates of Florida, Ormond Beach

Revival Research, Doral

Dermatology Consulting Services, Tampa

Forward Clinical Trials, Tampa

Clinical Physiology Associates, Fort Myers

Total Skin and Dermatology Center, PC., Birmingham

Pinnacle Research Group, LLC, Anniston

Dermatology Specialists Research, Louisville

Central Kentucky Research Associates, LLC, Lexington

Dermatologists of Greater Colombus, Bexley

Wright State Physicians, Fairborn

Dermatology Center of Indiana, PC, Plainfield

The Indiana Clinical Trials Center, Plainfield

Dawes Fretzin Clinical Research Group, Indianapolis

Unity Clinical Research, Oklahoma City

Vital Prospects Clinical Research Institute, Tulsa

Dermatology Treatment and Research Center, Dallas

Innovate Research, LLC, Fort Worth

The Center for Skin Research, Houston

Progressive Clinical Research, San Antonio

L.A. Universal Research Center, Inc., Los Angeles

Dermatology Research Associates, Los Angeles

Center for Dermatology Clinical Research, Inc., Fremont

Tufts Medical Center, Boston

ActivMed Practices and Research, Inc., Portsmouth

Institute of Skin Advancement Medical, Surgical, Costmetic & Laser Dermatology, Calgary

Innovaderm Research, Inc., Montreal

Ontario Inc., Ottawa

York Regional Dermatology, Richmond Hill

NewLab Clinical Research, Inc., St. John's

AvantDerm, Toronto

SkinWISE Dermatology, Winnipeg